Stryker (LTS:0R2S) ROE % Adjusted to Book Value: 2.41% (As of Mar. 2026)


LTS:0R2S Stryker Corp LTS:0R2S
89 GF Score
Price $325.22
GF Value $410.28
Valuation Modestly Undervalued
! 1 Warning Sign
View Full Analysis

What is Stryker ROE % Adjusted to Book Value?

Stryker LTS:0R2S 89 ROE % Adjusted to Book Value is 2.41% as of Mar. 2026. GuruFocus rates LTS:0R2S with a GF Score™ of 89/100 and a GF Value™ of $410.28 (Modestly Undervalued). The stock has 1 warning sign investors should review.

Stryker's ROE % for the quarter that ended in Mar. 2026 was 13.13%. Stryker's PB Ratio for the quarter that ended in Mar. 2026 was 5.44. Stryker's ROE % Adjusted to Book Value for the quarter that ended in Mar. 2026 was 2.41%.

Stryker ROE % Adjusted to Book Value Related Terms

Stryker ROE % Adjusted to Book Value Historical Data

* Premium members only.

The historical data trend for Stryker's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Stryker ROE % Adjusted to Book Value Chart

Stryker Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
ROE % Adjusted to Book Value
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.07 2.70 2.96 2.29 2.50

Stryker Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
ROE % Adjusted to Book Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.87 2.36 2.46 2.54 2.41

LTS:0R2S vs MDT, ABT, BSX: ROE % Adjusted to Book Value Comparison

For the Medical Devices subindustry, Stryker's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Stryker ROE % Adjusted to Book Value vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Stryker's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Stryker's ROE % Adjusted to Book Value falls into.


LTS:0R2S
89GF Score
Stryker Corp LTS:0R2S
ROE % Adjusted to Book Value is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Stryker ROE % Adjusted to Book Value Calculation

Stryker's ROE % Adjusted to Book Value for the fiscal year that ended in Dec. 2025 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=15.08% / 6.04
=2.50%

Stryker's ROE % Adjusted to Book Value for the quarter that ended in Mar. 2026 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=13.13% / 5.44
=2.41%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a ROE % Adjusted to Book Value of 2.41% mean?
Stryker (LTS:0R2S) has a ROE % Adjusted to Book Value of 2.41% as of Mar. 2026. Return on equity adjusted to book is the ratio of return on equity to price-book ratio. View historical data on Stryker and its competitors.
Is Stryker's ROE % Adjusted to Book Value too high?
Stryker's current ROE % Adjusted to Book Value is 2.41%. Overall, Stryker has a GF Score™ of 89/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Stryker's ROE % Adjusted to Book Value compare to MDT and ABT?
Stryker's ROE % Adjusted to Book Value of 2.41% can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROE % Adjusted to Book Value for a Medical Devices & Instruments company?
A good ROE % Adjusted to Book Value depends on the Medical Devices & Instruments industry context. However, ROE % Adjusted to Book Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROE % Adjusted to Book Value mean?
A high ROE % Adjusted to Book Value can signal that a stock is expensive relative to its fundamentals. Return on equity adjusted to book is the ratio of return on equity to price-book ratio. View historical data on Stryker and its competitors. Stryker's current ROE % Adjusted to Book Value is 2.41%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Stryker stock overvalued right now?
Based on GuruFocus' analysis, Stryker (LTS:0R2S) is currently considered Modestly Undervalued. The stock's GF Value™ is $410.28, compared to a current price of $325.22 — trading 20.7% below its estimated fair value. The current ROE % Adjusted to Book Value is 2.41%. Stryker's overall GF Score™ is 89/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROE % Adjusted to Book Value calculated?
ROE % Adjusted to Book Value is calculated from a company's financial statements. For Stryker (LTS:0R2S), the current ROE % Adjusted to Book Value is 2.41% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Stryker (LTS:0R2S) Overvalued in 2026?

Based on GuruFocus' analysis, Stryker stock appears to be undervalued. The current stock price of $325.22 is trading 20.7% below its estimated GF Value™ of $410.28. GuruFocus considers Stryker to be Modestly Undervalued.

Key valuation signals for LTS:0R2S:

  • ROE % Adjusted to Book Value: 2.41%
  • GF Value™: $410.28 vs. price of $325.22 (20.7% below fair value)
  • GF Score™: 89/100 with 1 warning sign

No single metric tells the full story. See the LTS:0R2S stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Stryker Business Description

Address 1941 Stryker Way, Portage, MI, USA, 49002
Stryker designs, manufactures, and markets an array of medical equipment, instruments, consumable supplies, and implantable devices. The product portfolio includes hip and knee replacements, extremities, endoscopy systems, operating room equipment, embolic coils, hospital beds and gurneys, and orthopedic robotics. Stryker remains one of the three largest competitors in reconstructive orthopedic implants and holds the leadership position in operating room equipment. Roughly one-fourth of Stryker's total revenue currently comes from outside the United States.
89GF Score

Get the complete analysis for LTS:0R2S

ROE % Adjusted to Book Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$325.22
Price
$410.28
GF Value